oleanolic acid has been researched along with Cerebral Infarction, Middle Cerebral Artery in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 2 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Huang, J; Ma, H; Wang, Y; Wang, Z; Yao, Z; Yu, J; Zhang, L; Zhang, W; Zhuang, C | 1 |
| Cao, X; Chen, B; Chen, J; Li, W; Song, L; Wang, S; Wang, X; Xu, Y; Yu, H; Zhao, Y | 1 |
| Chen, J; Leak, RK; Li, Q; Li, S; Shi, Y; Sun, Y; Yang, T; Zhang, F | 1 |
| Albala, B; Chopp, M; Cui, Y; Kapke, A; Lu, M; Nagafuji, T; Ninomiya, M; Roberts, C; Zhang, C; Zhang, L; Zhang, RL; Zhang, ZG | 1 |
| Bae, K; Ban, JY; Cho, SO; Ju, HS; Kim, JY; Lee, IS; Seong, YH; Song, KS | 1 |
| Fujimoto, M; Matsuo, Y; Ninomiya, M | 1 |
6 other study(ies) available for oleanolic acid and Cerebral Infarction, Middle Cerebral Artery
| Article | Year |
|---|---|
Discovery of bardoxolone derivatives as novel orally active necroptosis inhibitors.
Topics: Administration, Oral; Animals; Cell Survival; Cells, Cultured; Dose-Response Relationship, Drug; Drug Discovery; Female; Humans; Infarction, Middle Cerebral Artery; Male; Mice; Mice, Inbred C57BL; Molecular Structure; Necroptosis; Oleanolic Acid; Rats; Rats, Sprague-Dawley; Structure-Activity Relationship; Systemic Inflammatory Response Syndrome | 2021 |
Echinocystic acid, a natural plant extract, alleviates cerebral ischemia/reperfusion injury via inhibiting the JNK signaling pathway.
Topics: Animals; Apoptosis; Behavior, Animal; Dose-Response Relationship, Drug; Infarction, Middle Cerebral Artery; JNK Mitogen-Activated Protein Kinases; Male; MAP Kinase Signaling System; Mice; Mice, Inbred ICR; Oleanolic Acid; Phosphorylation; Reperfusion Injury; Transcription Factor RelA | 2019 |
Ischemic preconditioning provides long-lasting neuroprotection against ischemic stroke: The role of Nrf2.
Topics: Animals; Brain; Infarction, Middle Cerebral Artery; Ischemic Preconditioning; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Neurons; Neuroprotective Agents; NF-E2-Related Factor 2; Oleanolic Acid; Recovery of Function | 2020 |
Synergistic effect of an endothelin type A receptor antagonist, S-0139, with rtPA on the neuroprotection after embolic stroke.
Topics: Animals; Blood Platelets; Blood-Brain Barrier; Brain; Caffeic Acids; Collagen Type IV; Drug Synergism; Endothelin Receptor Antagonists; Fibrinolytic Agents; Immunohistochemistry; Infarction, Middle Cerebral Artery; Intercellular Adhesion Molecule-1; Male; Neuroprotective Agents; Oleanolic Acid; Rats; Rats, Wistar; Receptor, PAR-1; Recovery of Function; Tight Junctions; Tissue Plasminogen Activator | 2008 |
Anti-ischemic activities of aralia cordata and its active component, oleanolic acid.
Topics: Animals; Aralia; Brain Ischemia; Calcium; Cell Culture Techniques; Cell Death; Hydrogen Peroxide; Infarction, Middle Cerebral Artery; Neurons; Neuroprotective Agents; Oleanolic Acid; Plant Extracts; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species | 2009 |
Protective effect of endothelin type A receptor antagonist on brain edema and injury after transient middle cerebral artery occlusion in rats.
Topics: Animals; Blood-Brain Barrier; Brain; Brain Chemistry; Brain Edema; Caffeic Acids; Disease Models, Animal; Dose-Response Relationship, Drug; Endothelin Receptor Antagonists; Endothelin-1; Endothelins; Infarction, Middle Cerebral Artery; Ischemic Attack, Transient; Male; Neuroprotective Agents; Oleanolic Acid; Peroxidase; Rats; Rats, Wistar; Receptor, Endothelin A; Reperfusion Injury; Survival Rate; Time Factors; Water | 2001 |